Monsanto #0029

Identity & Overview

Monsanto Company was an American agrochemical and agricultural biotechnology corporation founded in 1901, headquartered in Creve Coeur, Missouri. **Founding & Original Leadership:** The Monsanto Chemical Works was founded in 1901 by John F. Queeny (1859–1933), a purchasing agent for a wholesale drug company, to manufacture the synthetic sweetener saccharin, then produced only in Germany. Queeny invested $1,500 of his own money and borrowed another $3,500 from a local Epsom salts manufacturer to launch his new company, which he named Monsanto, after his wife’s maiden name. The company was not built by a conventional startup founding team — it was a solo industrial enterprise that evolved through dynastic leadership. **Second-Generation Leadership:** Queeny passed control of the company to his son, Edgar M. Queeny (1897–1968), in 1928. Edgar Queeny transformed Monsanto into an industrial giant before he retired in 1960. **Key 20th-Century Builders:** Edgar Queeny turned over the chair of Monsanto to Charles Thomas, one of the founders of the research and development laboratory so important to Monsanto. Charlie Sommer, who had joined the company in 1929, became president. Under their combined leadership Monsanto saw several important developments, including the establishment of the Agricultural Chemicals division. **Modern CEO Architecture:** Increasing involvement in agricultural biotechnology dates from the installment of Richard Mahoney as Monsanto’s CEO in 1983. This involvement increased under the leadership of Robert Shapiro, appointed CEO in 1995, leading ultimately to the disposition of product lines unrelated to agriculture. Hugh Grant was the last CEO of Monsanto until its acquisition by Bayer. In 2003, he became president and chief executive officer and joined the board of directors. **Late-Stage Executive Team (at acquisition):** The Executive Team at closing included: chief financial officer Pierre Courduroux, chief technology officer Dr. Robert Fraley, chief of staff and community relations Janet Holloway, chief human resources officer Steven Mizell, chief strategy officer Kerry Preete, controller Nicole Ringenberg, and secretary and general counsel David Snively. **Core Business Model:** Monsanto’s modern incarnation operated on a two-pillar model: Monsanto’s operations were primarily divided into seeds and genomics, and agricultural productivity. These divisions allowed Monsanto to offer a diverse range of products, from genetically modified seeds to the widely used herbicide Roundup. Their GMO seeds — including crops like cotton, soy, corn, alfalfa, sorghum, and canola — were designed to work in tandem with Roundup. The system created a closed-loop dependency: Bayer (formerly Monsanto) created its famous Roundup Ready seed line intentionally designed to grow most optimally when treated with Monsanto’s Roundup pesticide. Roundup Ready products pushed farmers into a “pesticide treadmill,” in which they were dependent on both Bayer’s seeds and chemical inputs for a healthy crop. —

Market Position

In 2015, Monsanto was the world’s biggest supplier of seeds, controlling 26% of the global seed market (Du Pont was second with 21%). At its peak, the company occupied an unrivaled dominant position in agricultural biotechnology. **Competitive Landscape:** Key rivals included Syngenta, a frontrunner in agricultural science whose emphasis on crop protection and seeds cemented its status as a significant entity — following its acquisition by ChemChina in 2017, Syngenta continued to innovate. Corteva Agriscience, after becoming a standalone company from DowDuPont in 2019, provided a broad spectrum of seeds and crop protection solutions. BASF, known for its chemical prowess, achieved considerable advancements in agriculture, especially in crop protection and biotechnology. **Market Consolidation Context:** The agriculture supply industry witnessed consolidation with three major mergers, of which the Monsanto–Bayer merger was the biggest. The other two were DowDuPont and Syngenta–ChemChina. Post-consolidation, the same four multinational corporations — Bayer-Monsanto, Syngenta, BASF, and DowDuPont — control 75% of plant breeding research, 60% of the commercial seed market, and 76% of global agrochemical sales. —

Traction & Scale

• Seed Market Penetration:** Monsanto’s biotech seeds and traits (including those licensed to other companies) accounted for almost 90% of the total world area devoted to GM seeds by 2007. As of 2005, 87% of U.S. soybean fields were planted with glyphosate-resistant varieties.
• Employee Count:** As of August 31, 2017, Monsanto employed approximately 20,500 regular employees worldwide and approximately 2,800 temporary employees.
• Geographic Reach:** In 1998, Monsanto purchased Cargill’s international seed business, which gave it access to sales and distribution facilities in 51 countries. The company had major operations across North America, Latin America, Europe, and Asia-Pacific.
• Key Milestones:**
• Monsanto scientists were among the first to genetically modify a plant cell, publishing their results in 1983. Five years later the company conducted the first field tests of genetically modified crops.
• In 1996, genetically modified Roundup Ready soybeans resistant to Roundup became commercially available, followed by Roundup Ready corn in 1998.
• In 2005, Monsanto finalized the purchase of Seminis Inc, a leading global vegetable and fruit seed company, for $1.4 billion. This made it the world’s largest conventional seed company.
• By 2007, Roundup was the most used herbicide in the United States — being used on farms, by homeowners, and in government and industry.
• In 2018, the company ranked 199th on the Fortune 500 of the largest United States corporations by revenue.

Financial Picture

Monsanto was a publicly traded company on the NYSE under ticker symbol “MON” from 2002 until its delisting in 2018. **Revenue:** In 2017 the company made revenue of $14.64 billion USD, an increase over 2016 revenue of $13.50 billion USD. **Earnings:** In 2017 the company made EBIT of $3.26 billion USD, an increase over its 2016 EBIT of $2.40 billion USD. **Market Capitalization:** On June 6, 2018, Monsanto had a market cap of $56.46 billion USD. **Acquisition Price:** Bayer announced on June 7, 2018 that it completed its $63 billion acquisition of Monsanto. Bayer had announced its intention to acquire Monsanto in May 2016 and formally announced the deal for $128 per share in September 2016. **Regulatory Divestiture Costs:** The Department of Justice required Bayer AG to divest businesses and assets collectively worth approximately $9 billion in order to proceed with its proposed $66 billion acquisition of Monsanto Company. **Post-Acquisition Litigation Costs:** The company agreed to settle mass litigation in multiple states for $10 billion in 2020 and received preliminary court approval for a $7.25 billion settlement in March 2026. According to the 2025 financial statement filed by Bayer, the company’s total liabilities related to litigation totaled $11.25 billion. —

Public Sentiment

Monsanto was arguably the most polarizing corporation in the agricultural sector for the better part of three decades. Public perception bifurcated sharply between proponents of biotechnology-driven food production and a broad coalition of critics. **Anti-GMO and Farmer Sentiment:** Monsanto’s business strategies faced scrutiny, especially its aggressive enforcement of seed patents. The company was accused of surveillance and litigation against farmers suspected of illegally saving patented seeds. These “seed policing” actions generated controversy and accusations of corporate overreach. Many farmers faced costly legal battles, eroding trust with the company. Monsanto aggressively protected its patented GMO seeds through legal action, filing 147 patent infringement lawsuits against farmers between 1997 and 2010. Their strict enforcement prevented traditional seed-saving practices and forced farmers to purchase new seeds annually, creating a dependency on their products. **Cancer Litigation and Public Health Fears:** Thousands of lawsuits alleged that exposure to glyphosate caused non-Hodgkin’s lymphoma, a type of blood cancer. In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.” **Scientific Integrity Concerns:** In one court ruling, U.S. District Judge Vince Chhabria stated that the evidence “easily supported a conclusion that Monsanto was more concerned with tamping down safety inquiries and manipulating public opinion than it was with ensuring its product is safe.” **Social Media and Cultural Tone:** The relentless march of Monsanto Facebook memes (“Not sure if trying to feed the world or poison it”) and anti-GMO sentiment only pushed Monsanto further into the “evil” camp, with states legislating around GMO labeling. **Ethical Rankings:** In 2010, Swiss research firm Covalence rated Monsanto the least ethical of 581 multinational corporations based on their EthicalQuote reputation tracking index. In contrast, the journal Science ranked Monsanto in its Top 20 Employers list between 2011 and 2014, describing the company as an “innovative leader in the industry” that “makes changes needed” and “does important quality research.” **Farmer Alarm at Merger:** A survey found that 84% of farmers were “very concerned” about the Bayer-Monsanto merger. —

Media & Press

• Major Positive Coverage:**
• In 2009, Monsanto was chosen as Forbes magazine’s Company of the Year.
• Monsanto executive Robert Fraley won the World Food Prize for “breakthrough achievements in founding, developing, and applying modern agricultural biotechnology.”
• Major Controversies:**
• **Agent Orange:** Monsanto’s agricultural division focused on herbicides, including being one of the companies that produced Agent Orange, the controversial herbicide used by U.S. military forces during the Vietnam War. Agent Orange was later linked to cancer and other serious health problems.
• **PCB Contamination:** Monsanto added polychlorinated biphenyls (PCBs) to its product line, used in electrical equipment. PCBs were later found to pose serious health risks to fetuses and children and were banned in the U.S. in 1979, two years after Monsanto stopped producing them.
• **Roundup / Glyphosate Litigation:** On August 10, 2018, Dewayne Johnson, who has non-Hodgkin’s lymphoma, was awarded $289 million in damages (cut to $78 million pending appeal, then reduced to $21 million after appeal) after a jury in San Francisco found that Monsanto had failed to adequately warn consumers of cancer risks posed by the herbicide.
• **Ghostwriting Scandal:** Monsanto internal emails made public in August 2017 during the Johnson v. Monsanto Co. litigation revealed Monsanto personnel referring to undisclosed ghostwriting of safety papers. A paper in Regulatory Toxicology and Pharmacology was retracted on November 28, 2025 by the editor-in-chief, citing “lack of authorial independence,” “misrepresentation of contributions,” and questions about whether conclusions were adequately supported by the scientific data.
• **Revolving Door Criticism:** Critics argued that connections between the company and the government allowed Monsanto to obtain favorable regulations at the expense of consumer safety. Prominent cases included Linda J. Fisher moving from EPA Assistant Administrator to Monsanto VP and back; and William D. Ruckelshaus serving as EPA Administrator before joining Monsanto’s Board.
• **Bribery:** Monsanto was fined $1.5 million for bribing Indonesian officials.
• **Worst Merger Designation:** Owing to the massive financial and reputational setbacks caused by ongoing litigation concerning Monsanto’s herbicide Roundup, the Bayer-Monsanto merger is considered one of the worst corporate mergers in history.

Current Status

The Monsanto brand no longer exists as a legal corporate entity. The sale closed on June 7, 2018; Bayer announced its intent to discontinue the Monsanto name, with the combined company operating solely under the Bayer brand. This may have been a strategic way to distance Bayer from the negative association that had developed between the name Monsanto and genetically modified organisms and genetically engineered seeds. However, the Monsanto legal entity persists in litigation. Monsanto/Bayer has faced over 192,000 Roundup lawsuits since the start of litigation. Despite previously settling thousands of lawsuits, Bayer is still facing approximately 58,000 active Roundup cancer claims. **2026 Settlement Attempt:** On February 17, 2026, Monsanto announced a proposed U.S. nationwide class settlement designed to resolve current and future Roundup claims alleging non-Hodgkin lymphoma injuries through a long-term claims program, with funding totaling up to $7.25 billion over up to 21 years, pending court approval. **Supreme Court Involvement:** On January 16, 2026, the U.S. Supreme Court announced that it will review the Durnell Roundup case. Monsanto petitioned the court to hear Durnell in April 2025, addressing the split in authority among federal circuit courts on the application of federal preemption. **Bayer’s Financial Damage:** Bayer shares have fallen by almost half since the buyout. To date, Bayer has paid over $10 billion to settle a portion of the claims but faces approximately 67,000 lawsuits that remain pending as of May 2025. In response, Bayer is reportedly exploring the possibility of placing its Monsanto subsidiary into Chapter 11 bankruptcy, presumably as a means to isolate and manage these liabilities. **Bayer’s Lobbying Offensive:** Bayer spent $9.2 million in 2025 to hire scores of lobbyists from more than a dozen firms to push its agenda in Congress and multiple executive branch departments. The trajectory is one of terminal brand death paired with metastatic legal liability. Monsanto’s product brands — Roundup, Roundup Ready, DEKALB — survive inside Bayer’s Crop Science division, but the corporate name has been erased and the underlying assets remain in active litigation dispute. —

SUMMARY VERDICT — MONSANTO COMPANY

Monsanto is one of the most consequential and controversial corporations in modern industrial history. Founded as a saccharin manufacturer in 1901, it became the dominant force in global agricultural biotechnology over the course of a century — controlling 26% of the world seed market at its peak, deploying GMO traits across 90% of the world’s genetically modified crop area, and generating $14.64 billion in revenue in its final year as an independent company.

The business model was genuinely brilliant in its architecture: a closed-loop system binding farmers to both the seed and the chemical, creating structural dependency at industrial scale. The Roundup Ready platform alone reshaped global agriculture. By any conventional metric of market penetration, revenue growth, and technological influence, Monsanto was a category-defining company.

The fatal flaw was the accumulation of liability — legal, reputational, and moral — that proved impossible to contain. The $63 billion Bayer acquisition in 2018 is now widely regarded as one of the worst corporate mergers in history. Between 2023 and 2025, plaintiffs won nearly $5 billion in verdicts, and Bayer has paid over $10 billion in settlements since acquiring Monsanto, with approximately 65,000 lawsuits still pending as of early 2026. Yahoo Finance A $7.25 billion class-action settlement proposed in February 2026 — the company’s most significant resolution effort since 2020 — is designed to cover both current and future non-Hodgkin lymphoma claims, pending final court approval expected in July 2026. Monsanto Roundup Bayer has engaged advisors to explore placing Monsanto into Chapter 11 bankruptcy as a means of isolating and managing remaining liabilities. King Law

Based on a first estimate of all litigation-related payouts of approximately 5 billion euros in 2026 alone, Bayer expects negative free cash flow for the year. Bayer Bayer’s share price has fallen by nearly half since the acquisition closed.

The Monsanto name was erased in 2018. Its product brands — Roundup, Roundup Ready, DEKALB — survive inside Bayer’s Crop Science division. The legal entity persists only in courtrooms.

One-line assessment: Monsanto built a global agricultural empire on technological dominance and legal force — then became the clearest modern example of what happens when a corporation mistakes market control for immunity from consequence.